Bio Protocol vs Plasma — how do they compare? Bio Protocol trades at Rp499.71 (market cap Rp1,12T, Rp283,83M 24h volume), while Plasma trades at Rp1,605 (market cap Rp4,19T, Rp1,21T 24h volume). The key difference: Plasma is far larger — about 3.7× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Plasma's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Plasma for 24 Days on average.
| BIO | XPL | |
|---|---|---|
Market Cap | Rp1,12T | Rp4,19T |
Volume (24h) | Rp283,83M | Rp1,21T |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 2,6B XPL |
Typical Hold Time | 16 Days | 24 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Plasma (XPL) is trading at Rp1,627 with a bearish technical outlook, as indicated by moving averages and overall signals. The token's RSI_6 at 23.99 suggests potential oversold conditions, while support levels near Rp1,479 offer downside protection. Recent ecosystem activity is limited, with no major protocol updates reported. Market cap stands at Rp4.23 trillion, reflecting moderate valuation in the crypto space.
Outlook remains cautious due to bearish technicals and low network activity. Key opportunities include oversold bounce potential from support zones, but risks involve low liquidity and absence of fundamental catalysts. Investors should monitor for any new development updates or exchange listings that could drive momentum.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Plasma is a Layer 1 blockchain designed to power the global stablecoin economy. Built for fast, zero-fee USDT payments and customizable gas tokens, it enables borderless, permissionless access to financial services. With its global payments network and integrated products, Plasma is establishing itself as the native chain for stablecoin transactions.
Read more on XPL →